Deuruxolitinib Phosphate + Mao Inhibitors Interaction
Contraindicatedinteraction on record
Description
LEQSELVI is contraindicated in patients taking moderate or strong CYP2C9 inhibitors. Concomitant use increases deuruxolitinib exposure and may increase risk of serious adverse reactions such as thrombosis.
Mechanism
CYP2C9 inhibition increases deuruxolitinib exposure
Source: NLP:deuruxolitinib phosphate